Synthetic and Natural Agents Targeting Advanced Glycation End-Products for Skin Anti-Aging: A Comprehensive Review of

Joon Yong Choi1,2, Nam Gyoung Ha3,4,5, Weon Ju Lee3,4,5

  • 1Department of Biomedical Science, The Graduate School, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.

PubMed

Insights

Advanced glycation end-products (AGEs) accelerate skin aging. This review explores how targeting glycation with natural or synthetic agents can reduce AGEs and improve skin health, offering potential anti-aging benefits.

Area of Science:

  • Dermatology
  • Cosmetology
  • Biochemistry

Background:

  • Advanced glycation end-products (AGEs) contribute to diabetic complications and skin aging.
  • Glycation stress negatively impacts skin cell viability, collagen structure, and fibrillin-1 expression.
  • These detrimental effects manifest as aesthetic, physical, and functional skin changes.

Purpose of the Study:

  • To review the significance of glycation-induced skin aging.
  • To examine the therapeutic potential of glycation-targeting strategies for skin anti-aging.
  • To cover experimental and clinical studies on interventions against glycation-induced skin aging.

Main Methods:

  • Review of experimental and clinical studies on glycation and skin aging.
  • Analysis of the effects of glycation stress on skin cells and collagen.
  • Evaluation of interventions, including synthetic and natural agents, with antiglycation or antioxidant activity.

Main Results:

  • Glycation stress reduces cell viability, collagen lattice contraction, and fibrillin-1 expression.
  • Increased collagen cross-linking due to glycation prolongs breakdown time.
  • Synthetic and natural agents attenuated AGE levels and improved skin aging parameters.

Conclusions:

  • Dietary or topical agents with antiglycation/antioxidant properties can mitigate AGE-induced skin aging.
  • Interventions can improve skin color, wrinkles, elasticity, hydration, and dermal density.
  • Supplements or formulations with antiglycation agents show promise for combating skin aging.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.6K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
272
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.8K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.0K